Impact of asymptomatic herpes simplex virus type 2 infection on mucosal homing and immune cell subsets in the blood and female genital tract

Journal of Immunology

Volumn 192, Issue 11, 2014, Pages 5074-5082

  Shannon, Brett ^a   Yi, Tae Joon ^a   Thomas Pavanel, Jamie ^b   Chieza, Lisungu ^b   Janakiram, Praseedha ^b   Saunders, Megan ^b   Tharao, Wangari ^b   Huibner, Sanja ^a   Remis, Robert ^c,d   Rebbapragada, Anu ^a,d   Kaul, Rupert ^a,e  

^a UNIVERSITY OF TORONTO   (Canada)

^b Women's Health in Women's Hands Community Health Centre   (Canada)

^c UNIVERSITY OF TORONTO   (Canada)

^d PUBLIC HEALTH ONTARIO   (Canada)

^e UNIVERSITY HEALTH NETWORK   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA4 INTEGRIN; CD38 ANTIGEN; CHEMOKINE RECEPTOR CCR5; HLA DR ANTIGEN; INTEGRIN ALPHA4BETA7; LECTIN; MANNOSE RECEPTOR; UNCLASSIFIED DRUG;

ADULT; AFRICAN CARIBBEAN; ANTIGEN EXPRESSION; ARTICLE; ASYMPTOMATIC INFECTION; BLOOD CELL; CANADA; CD4+ T LYMPHOCYTE; CELL SUBPOPULATION; CLINICAL ARTICLE; CONTROLLED STUDY; DENDRITIC CELL; FEMALE; HERPES SIMPLEX; HERPES SIMPLEX VIRUS 2; HUMAN; HUMAN CELL; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; IMMUNOCOMPETENT CELL; INFECTION SENSITIVITY; LYMPHOCYTE COUNT; LYMPHOCYTE HOMING; MUCOSAL IMMUNITY; NONHUMAN; PRIORITY JOURNAL; T LYMPHOCYTE ACTIVATION; UTERINE CERVIX MUCOSA; YOUNG ADULT;

ADULT; CD4-POSITIVE T-LYMPHOCYTES; CERVIX UTERI; DENDRITIC CELLS; FEMALE; GENE EXPRESSION REGULATION; HERPES GENITALIS; HERPESVIRUS 2, HUMAN; HUMANS; INTEGRINS; MALE; MIDDLE AGED; T-LYMPHOCYTE SUBSETS;

EID: 84901257569     PISSN: 00221767     EISSN: 15506606     Source Type: Journal    
DOI: 10.4049/jimmunol.1302916     Document Type: Article

References (50)

1. Benedetti, J., L. Corey, and R. Ashley. 1994. Recurrence rates in genital herpes after symptomatic first-episode infection. Ann. Intern. Med. 121: 847-854.
2. Freeman, E. E., H. A. Weiss, J. R. Glynn, P. L. Cross, J. A. Whitworth, and R. J. Hayes. 2006. Herpes simplex virus 2 infection increases HIV acquisition in men and women: systematic review and meta-analysis of longitudinal studies. AIDS 20: 73-83.
3. Rebbapragada, A., C. Wachihi, C. Pettengell, S. Sunderji, S. Huibner, W. Jaoko, B. Ball, K. Fowke, T. Mazzulli, F. A. Plummer, and R. Kaul. 2007. Negative mucosal synergy between Herpes simplex type 2 and HIV in the female genital tract. AIDS 21: 589-598.
4. Wald, A. 2004. Herpes simplex virus type 2 transmission: risk factors and virus shedding. Herpes 11(Suppl. 3): 130A-137A.
5. Zhu, J., F. Hladik, A. Woodward, A. Klock, T. Peng, C. Johnston, M. Remington, A. Magaret, D. M. Koelle, A. Wald, and L. Corey. 2009. Persistence of HIV-1 receptor-positive cells after HSV-2 reactivation is a potential mechanism for increased HIV-1 acquisition. Nat. Med. 15: 886-892.
6. Prodger, J. L., R. Gray, G. Kigozi, F. Nalugoda, R. Galiwango, K. Nehemiah, M. Kakanga, T. Hirbod, M. J. Wawer, N. Sewankambo, et al; Rakai Genital Immunology Research Group. 2012. Impact of asymptomatic Herpes simplex virus-2 infection on T cell phenotype and function in the foreskin. AIDS 26: 1319-1322.
7. Johnson, K. E., A. D. Redd, T. C. Quinn, A. N. Collinson-Streng, T. Cornish, X. Kong, R. Sharma, A. A. Tobian, B. Tsai, M. E. Sherman, et al. 2011. Effects of HIV-1 and herpes simplex virus type 2 infection on lymphocyte and dendritic cell density in adult foreskins from Rakai, Uganda. J. Infect. Dis. 203: 602-609.
8. Margolis, L., and R. Shattock. 2006. Selective transmission of CCR5-utilizing HIV-1: the 'gatekeeper' problem resolved? Nat. Rev. Microbiol. 4: 312-317.
9. Bargatze, R. F., M. A. Jutila, and E. C. Butcher. 1995. Distinct roles of L-selectin and integrins alpha 4 beta 7 and LFA-1 in lymphocyte homing to Peyer's patch- HEV in situ: the multistep model confirmed and refined. Immunity 3: 99-108.
10. Arthos, J., C. Cicala, E. Martinelli, K. Macleod, D. Van Ryk, D. Wei, Z. Xiao, T. D. Veenstra, T. P. Conrad, R. A. Lempicki, et al. 2008. HIV-1 envelope protein binds to and signals through integrin alpha4beta7, the gut mucosal homing receptor for peripheral T cells. Nat. Immunol. 9: 301-309.
11. Cicala, C., E. Martinelli, J. P. McNally, D. J. Goode, R. Gopaul, J. Hiatt, K. Jelicic, S. Kottilil, K. Macleod, A. O'Shea, et al. 2009. The integrin alpha4beta7 forms a complex with cell-surface CD4 and defines a T-cell subset that is highly susceptible to infection by HIV-1. Proc. Natl. Acad. Sci. USA 106: 20877-20882.
12. Martinelli, E., H. Tharinger, I. Frank, J. Arthos, M. Piatak, Jr., J. D. Lifson, J. Blanchard, A. Gettie, and M. Robbiani. 2011. HSV-2 infection of dendritic cells amplifies a highly susceptible HIV-1 cell target. PLoS Pathog. 7: e1002109.
13. Turville, S. G., P. U. Cameron, A. Handley, G. Lin, S. Pöhlmann, R. W. Doms, and A. L. Cunningham. 2002. Diversity of receptors binding HIV on dendritic cell subsets. Nat. Immunol. 3: 975-983.
14. Turville, S. G., J. J. Santos, I. Frank, P. U. Cameron, J. Wilkinson, M. Miranda- Saksena, J. Dable, H. Stössel, N. Romani, M. Piatak, Jr., et al. 2004. Immunodeficiency virus uptake, turnover, and 2-phase transfer in human dendritic cells. Blood 103: 2170-2179.
15. McDonald, D., L. Wu, S. M. Bohks, V. N. KewalRamani, D. Unutmaz, and T. J. Hope. 2003. Recruitment of HIV and its receptors to dendritic cell-T cell junctions. Science 300: 1295-1297.
16. Geijtenbeek, T. B., D. S. Kwon, R. Torensma, S. J. van Vliet, G. C. van Duijnhoven, J. Middel, I. L. Cornelissen, H. S. Nottet, V. N. KewalRamani, D. R. Littman, et al. 2000. DC-SIGN, a dendritic cell-specific HIV-1-binding protein that enhances trans-infection of T cells. Cell 100: 587-597.
17. Steinman, R. M., A. Granelli-Piperno, M. Pope, C. Trumpfheller, R. Ignatius, G. Arrode, P. Racz, and K. Tenner-Racz. 2003. The interaction of immunodeficiency viruses with dendritic cells. Curr. Top. Microbiol. Immunol. 276: 1-30.
18. de Witte, L., A. Nabatov, M. Pion, D. Fluitsma, M. A. de Jong, T. de Gruijl, V. Piguet, Y. van Kooyk, and T. B. Geijtenbeek. 2007. Langerin is a natural barrier to HIV-1 transmission by Langerhans cells. Nat. Med. 13: 367-371.
19. Fahrbach, K. M., S. M. Barry, S. Ayehunie, S. Lamore, M. Klausner, and T. J. Hope. 2007. Activated CD34-derived Langerhans cells mediate transinfection with human immunodeficiency virus. J. Virol. 81: 6858-6868.
20. Turville, S. G., J. Arthos, K. M. Donald, G. Lynch, H. Naif, G. Clark, D. Hart, and A. L. Cunningham. 2001. HIV gp120 receptors on human dendritic cells. Blood 98: 2482-2488.
21. Nguyen, D. G., and J. E. Hildreth. 2003. Involvement of macrophage mannose receptor in the binding and transmission of HIV by macrophages. Eur. J. Immunol. 33: 483-493.
22. Mosca, J. D., D. P. Bednarik, N. B. Raj, C. A. Rosen, J. G. Sodroski, W. A. Haseltine, and P. M. Pitha. 1987. Herpes simplex virus type-1 can reactivate transcription of latent human immunodeficiency virus. Nature 325: 67-70.
23. Reynolds, S. J., F. Makumbi, K. Newell, N. Kiwanuka, P. Ssebbowa, G. Mondo, I. Boaz, M. J. Wawer, R. H. Gray, D. Serwadda, and T. C. Quinn. 2012. Effect of daily aciclovir on HIV disease progression in individuals in Rakai, Uganda, coinfected with HIV-1 and herpes simplex virus type 2: a randomised, double-blind placebo-controlled trial. Lancet Infect. Dis. 12: 441-448.
24. Kaul, R., C. R. Cohen, D. Chege, T. J. Yi, W. Tharao, L. R. McKinnon, R. Remis, O. Anzala, and J. Kimani. 2011. Biological factors that may contribute to regional and racial disparities in HIV prevalence. Am. J. Reprod. Immunol. 65: 317-324.
25. Remis, R. S., J. Liu, M. Loutfy, W. Tharao, A. Rebbapragada, S. J. Perusini, L. Chieza, M. Saunders, L. Green-Walker, and R. Kaul. 2013. The epidemiology of sexually transmitted co-infections in HIV-positive and HIV-negative African- Caribbean women in Toronto. BMC Infect. Dis. 13: 550.
26. Ashley-Morrow, R., J. Nollkamper, N. J. Robinson, N. Bishop, and J. Smith. 2004. Performance of focus ELISA tests for herpes simplex virus type 1 (HSV-1) and HSV-2 antibodies among women in ten diverse geographical locations. Clin. Microbiol. Infect. 10: 530-536.
27. Biraro, S., P. Mayaud, R. A. Morrow, H. Grosskurth, and H. A. Weiss. 2011. Performance of commercial herpes simplex virus type-2 antibody tests using serum samples from Sub-Saharan Africa: a systematic review and meta-analysis. Sex. Transm. Dis. 38: 140-147.
28. Mujugira, A., R. A. Morrow, C. Celum, J. Lingappa, S. Delany-Moretlwe, K. H. Fife, R. Heffron, G. De Bruyn, B. Homawoo, E. Karita, et al; Partners in Prevention HSV/HIV Transmission Study Team. 2011. Performance of the Focus HerpeSelect-2 enzyme immunoassay for the detection of herpes simplex virus type 2 antibodies in seven African countries. Sex. Transm. Infect. 87: 238-241.
29. Nugent, R. P., M. A. Krohn, and S. L. Hillier. 1991. Reliability of diagnosing bacterial vaginosis is improved by a standardized method of gram stain interpretation. J. Clin. Microbiol. 29: 297-301.
30. Kessler, H. H., G. Muhlbauer, B. Rinner, E. Stelzl, A. Berger, H. W. Dörr, B. Santner, E. Marth, and H. Rabenau. 2000. Detection of Herpes simplex virus DNA by real-time PCR. J. Clin. Microbiol. 38: 2638-2642.
31. Moncrieffe, H., K. Nistala, Y. Kamhieh, J. Evans, A. Eddaoudi, S. Eaton, and L. R. Wedderburn. 2010. High expression of the ectonucleotidase CD39 on T cells from the inflamed site identifies two distinct populations, one regulatory and one memory T cell population. J. Immunol. 185: 134-143.
32. Gupta, R., T. Warren, and A. Wald. 2007. Genital herpes. Lancet 370: 2127- 2137.
33. McKinnon, L. R., and R. Kaul. 2012. Quality and quantity: mucosal CD4+ T cells and HIV susceptibility. Curr. Opin. HIV AIDS 7: 195-202.
34. Zhang, Z., T. Schuler, M. Zupancic, S. Wietgrefe, K. A. Staskus, K. A. Reimann, T. A. Reinhart, M. Rogan, W. Cavert, C. J. Miller, et al. 1999. Sexual transmission and propagation of SIV and HIV in resting and activated CD4+ T cells. Science 286: 1353-1357.
35. Baldauf, H. M., X. Pan, E. Erikson, S. Schmidt, W. Daddacha, M. Burggraf, K. Schenkova, I. Ambiel, G. Wabnitz, T. Gramberg, et al. 2012. SAMHD1 restricts HIV-1 infection in resting CD4(+) T cells. Nat. Med. 18: 1682-1687.
36. Thapa, M., W. A. Kuziel, and D. J. Carr. 2007. Susceptibility of CCR5-deficient mice to genital herpes simplex virus type 2 is linked to NK cell mobilization. J. Virol. 81: 3704-3713.
37. Posavad, C., L. Zhao, D. Mueller, M. L. Huang, B. Herold, A. Wald, and L. Corey. 2013. Persistence of mucosal T Cell responses to HSV-2 in the female genital tract (Abstr. W.96). In Proceedings of the 16th International Congress of Mucosal Immunology, July 17-20. Society of Mucosal Immunology, Vancouver, Canada p.72
38. Martinelli, E., F. Veglia, D. Goode, N. Guerra-Perez, M. Aravantinou, J. Arthos, M. Piatak, Jr., J. D. Lifson, J. Blanchard, A. Gettie, and M. Robbiani. 2013. The frequency of a4b7(high) memory CD4? T cells correlates with susceptibility to rectal simian immunodeficiency virus infection. J. Acquir. Immune Defic. Syndr. 64: 325-331.
39. Card, C. M., P. J. McLaren, C. Wachihi, J. Kimani, F. A. Plummer, and K. R. Fowke. 2009. Decreased immune activation in resistance to HIV-1 infection is associated with an elevated frequency of CD4(+)CD25(+)FOXP3(+) regulatory T cells. J. Infect. Dis. 199: 1318-1322.
40. Pillai, V., S. B. Ortega, C. K. Wang, and N. J. Karandikar. 2007. Transient regulatory T-cells: a state attained by all activated human T-cells. Clin. Immunol. 123: 18-29.
41. Watson-Jones, D., H. A. Weiss, M. Rusizoka, J. Changalucha, K. Baisley, K. Mugeye, C. Tanton, D. Ross, D. Everett, T. Clayton, et al; HSV trial team; Steering and Data Monitoring Committees. 2008. Effect of herpes simplex suppression on incidence of HIV among women in Tanzania. N. Engl. J. Med. 358: 1560-1571.
42. Celum, C., A. Wald, J. Hughes, J. Sanchez, S. Reid, S. Delany-Moretlwe, F. Cowan, M. Casapia, A. Ortiz, J. Fuchs, et al; HPTN 039 Protocol Team. 2008. Effect of aciclovir on HIV-1 acquisition in herpes simplex virus 2 seropositive women and men who have sex with men: a randomised, double-blind, placebocontrolled trial. Lancet 371: 2109-2119.
43. Yi, T. J., B. Shannon, L. Chieza, D. Su, M. Saunders, W. Tharao, S. Huibner, R. Remis, J. Raboud, and R. Kaul. 2014. Valacyclovir therapy does not reverse herpes-associated alterations in cervical immunology: a randomized, placebocontrolled crossover trial. J. Infect. Dis. DOI: 10.1093/infdis/jiu163.
44. Johnston, C., M. Saracino, S. Kuntz, A. Magaret, S. Selke, M. L. Huang, J. T. Schiffer, D. M. Koelle, L. Corey, and A. Wald. 2012. Standard-dose and high-dose daily antiviral therapy for short episodes of genital HSV-2 reactivation: three randomised, open-label, cross-over trials. Lancet 379: 641-647.
45. Martin, E. T., E. Krantz, S. L. Gottlieb, A. S. Magaret, A. Langenberg, L. Stanberry, M. Kamb, and A. Wald. 2009. A pooled analysis of the effect of condoms in preventing HSV-2 acquisition. Arch. Intern. Med. 169: 1233-1240.
46. Johnston, C., D. M. Koelle, and A. Wald. 2011. HSV-2: in pursuit of a vaccine. J. Clin. Invest. 121: 4600-4609.
47. Palliser, D., D. Chowdhury, Q. Y. Wang, S. J. Lee, R. T. Bronson, D. M. Knipe, and J. Lieberman. 2006. An siRNA-based microbicide protects mice from lethal herpes simplex virus 2 infection. Nature 439: 89-94.
48. Hunt, P. W., N. S. Shulman, T. L. Hayes, V. Dahl, M. Somsouk, N. T. Funderburg, B. McLaughlin, A. L. Landay, O. Adeyemi, L. E. Gilman, et al. 2013. The immunologic effects of maraviroc intensification in treated HIVinfected individuals with incomplete CD4+ T-cell recovery: a randomized trial. Blood 121: 4635-4646.
49. Trifonova, R. T., J. Lieberman, and D. van Baarle. 2014. Distribution of immune cells in the human cervix and implications for HIV transmission. Am. J. Reprod. Immunol. 71: 252-264.
50. Prakash, M., M. S. Kapembwa, F. Gotch, and S. Patterson. 2004. Chemokine receptor expression on mucosal dendritic cells from the endocervix of healthy women. J. Infect. Dis. 190: 246-250.